Evidence map›Paper›PMID 37896832›Full record

ArticleViruses2023

Higher HIV-1 Env gp120-Specific Antibody-Dependent Cellular Cytotoxicity (ADCC) Activity Is Associated with Lower Levels of Defective HIV-1 Provirus.

Ryan Yucha, Morgan L Litchford, Carolyn S Fish, Zak A Yaffe, Barbra A Richardson, Elizabeth Maleche-Obimbo, Grace John-Stewart, Dalton Wamalwa, Julie Overbaugh, Dara A Lehman

Abstract read
In one paragraph

Article in Viruses, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. HIV Virion Capturing Liposomes for Therapeutic Vaccination.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ryan YuchaHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Morgan L LitchfordHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.ORCID 0000-0001-7759-5928
Carolyn S FishHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Zak A YaffeHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Barbra A RichardsonDepartment of Global Health, University of Washington, Seattle, WA 98195, USA.
Elizabeth Maleche-ObimboDepartment of Pediatrics and Child Health, University of Nairobi, Nairobi P.O. Box 30197, Kenya.
Grace John-StewartDepartment of Global Health, University of Washington, Seattle, WA 98195, USA.
Dalton WamalwaDepartment of Global Health, University of Washington, Seattle, WA 98195, USA.
Julie OverbaughHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.
Dara A LehmanHuman Biology Division, Fred Hutchinson Cancer Center, Seattle, WA 98109, USA.ORCID 0000-0002-0372-0631

Funding

Translational Bioimaging Core Shared ResourceP30CA015704 · NCI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI Eric Collisson · 1985 to 2026
$296.4M
University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI CONNIE L CELUM · 1988 to 2026
$104.9M
Urgent Versus Post-Stabilization ART in HIV+ Children with Severe Co-infectionsR01HD023412 · NICHD · UNIVERSITY OF WASHINGTON · PI Grace C. John-Stewart, DALTON CHEKOKO WAMALWA · 1987 to 2026
$12.2M
THE ROLE OF ANTIBODIES IN MOTHER TO CHILD HIV TRANSMISSIONR01AI076105 · NIAID · FRED HUTCHINSON CANCER RESEARCH CENTER · PI OVERBAUGH, JULIE M. · 2008 to 2023
$8.8M
Infant immune mechanisms of HIV reservoir size and decayR01HD094718 · NICHD · UNIVERSITY OF WASHINGTON · PI JOHN-STEWART, GRACE C., LEHMAN, DARA ANN · 2017 to 2021
$3.6M
Health-Professional Education Partnership Initiative (HEPI) - KenyaR25TW011212 · FIC · UNIVERSITY OF NAIROBI · PI NDUATI, RUTH WANJIRU, WAMALWA, DALTON CHEKOKO · 2018 to 2022
$3.2M
FIC NIH HHS R25 TW011212NCI NIH HHS P30 CA015704NIAID NIH HHS P30 AI027757NIAID NIH HHS R01 AI076105NICHD NIH HHS R01 HD023412NICHD NIH HHS R01 HD094718
6 · The paper itself

Abstract

A cure for HIV-1 (HIV) remains unrealized due to a reservoir of latently infected cells that persist during antiretroviral therapy (ART), with reservoir size associated with adverse health outcomes and inversely with time to viral rebound upon ART cessation. Once established during ART, the HIV reservoir decays minimally over time; thus, understanding factors that impact the size of the HIV reservoir near its establishment is key to improving the health of people living with HIV and for the development of novel cure strategies. Yet, to date, few correlates of HIV reservoir size have been identified, particularly in pediatric populations. Here, we employed a cross-subtype intact proviral DNA assay (CS-IPDA) to quantify HIV provirus between one- and two-years post-ART initiation in a cohort of Kenyan children (n = 72), which had a median of 99 intact (range: 0-2469), 1340 defective (range: 172-3.84 × 10

Indexed as

HIV-1HIV InfectionsAntibody-Dependent Cell CytotoxicityCD4-Positive T-LymphocytesChildHumansKenyaProvirusesantibodyantibody-dependent cellular cytotoxicity (ADCC)CS-IPDAdefective provirusHIV-1HIV envelope (Env)HIV provirusHIV reservoirintact proviruspediatric HIV

Identifiers

PMID37896832
PMCPMC10611199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.